Setting

Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity

Published: 28 Sep 2020 | Report Code: 10247709 | Pages: 173

Global pharmaceutical continuous manufacturing market will reach $2,665.5 million by 2030, growing by 10.5% annually over 2020-2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity. Highlighted with 85 tables and 76 figures, this 173-page report “Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Integrated Continuous Systems Semi-Continuous Systems • Continuous Granulators • Continuous Blenders • Continuous Compressors • Continuous Coaters • Continuous Dryers • Other Semi-Continuous Systems Controls & Software Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. End Product Manufacturing • Solid Dosage Manufacturing • Liquid Dosage Manufacturing API Manufacturing Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Contract Manufacturing Organizations • Research Organizations and Institutes • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Technology, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): ACG Group Alexanderwerk Baker Perkins Ltd. Coperion GmbH Fette Compacting Freund-vector Corporation GEA Group AG Gebrüder Lödige Maschinenbau GmbH Gericke AG Glatt GmbH Hosokawa Micron Corporation Korsch AG Leistritz AG Munson Machinery Company, Inc. Powrex Corp Scott Equipment Company Sturtevant, Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	10
1.2 Research Methodology	13
1.2.1 Overview of Market Research Methodology	13
1.2.2 Market Assumption	14
1.2.3 Secondary Data	14
1.2.4 Primary Data	14
1.2.5 Data Filtration and Model Design	16
1.2.6 Market Size/Share Estimation	17
1.2.7 Research Limitations	18
1.3 Executive Summary	19
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Global Market by Product	43
3.1 Market Overview by Product	43
3.2 Integrated Continuous Systems	45
3.3 Semi-Continuous Systems	46
3.3.1 Continuous Granulators	48
3.3.2 Continuous Blenders	49
3.3.3 Continuous Compressors	50
3.3.4 Continuous Coaters	51
3.3.5 Continuous Dryers	52
3.3.6 Other Semi-Continuous Systems	53
3.4 Controls & Software	54
4 Segmentation of Global Market by Application	55
4.1 Market Overview by Application	55
4.2 End Product Manufacturing	57
4.2.1 Solid Dosage Manufacturing	59
4.2.2 Liquid Dosage Manufacturing	60
4.3 API Manufacturing	61
5 Segmentation of Global Market by End User	63
5.1 Market Overview by End User	63
5.2 Pharmaceutical Companies	65
5.3 Contract Manufacturing Organizations	66
5.4 Research Organizations and Institutes	67
5.5 Other End Users	68
6 Segmentation of Global Market by Region	69
6.1 Geographic Market Overview 2019-2030	69
6.2 North America Market 2019-2030 by Country	75
6.2.1 Overview of North America Market	75
6.2.2 U.S.	79
6.2.3 Canada	83
6.2.4 Mexico	85
6.3 European Market 2019-2030 by Country	87
6.3.1 Overview of European Market	87
6.3.2 Germany	91
6.3.3 UK	94
6.3.4 France	96
6.3.5 Spain	98
6.3.6 Italy	100
6.3.7 Russia	102
6.3.8 Rest of European Market	104
6.4 Asia-Pacific Market 2019-2030 by Country	106
6.4.1 Overview of Asia-Pacific Market	106
6.4.2 Japan	110
6.4.3 China	113
6.4.4 Australia	116
6.4.5 India	118
6.4.6 South Korea	120
6.4.7 Rest of APAC Region	122
6.5 South America Market 2019-2030 by Country	124
6.5.1 Argentina	127
6.5.2 Brazil	129
6.5.3 Chile	131
6.5.4 Rest of South America Market	133
6.6 MEA Market 2019-2030 by Country	134
6.6.1 UAE	137
6.6.2 Saudi Arabia	139
6.6.3 South Africa	141
6.6.4 Other National Markets	143
7 Competitive Landscape	144
7.1 Overview of Key Vendors	144
7.2 New Product Launch, Partnership, Investment, and M&A	147
7.3 Company Profiles	148
ACG Group	148
Alexanderwerk	150
Baker Perkins Ltd.	151
Coperion GmbH	152
Fette Compacting	153
Freund-vector Corporation	154
GEA Group AG	155
Gebrüder Lödige Maschinenbau GmbH	156
Gericke AG	157
Glatt GmbH	158
Hosokawa Micron Corporation	159
Korsch AG	160
Leistritz AG	161
Munson Machinery Company, Inc.	162
Powrex Corp	163
Scott Equipment Company	164
Sturtevant, Inc.	165
Thermo Fisher Scientific Inc.	166
8 Investing in Global Market: Risk Assessment and Management	167
8.1 Risk Evaluation of Global Market	167
8.2 Critical Success Factors (CSFs)	170
Related Reports and Products	173
List Of Tables

Table 1.  Snapshot of Global Pharmaceutical Continuous Manufacturing Market, 2019-2030	20
Table 2. Growth Rate of World Real GDP, 2017-2021	23
Table 3.  Main Product Trends and Market Opportunities in Global Pharmaceutical Continuous Manufacturing Market	33
Table 4. Global Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	43
Table 5. Global Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn	47
Table 6. Global Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	55
Table 7. Global Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn	58
Table 8. Global Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	63
Table 9. Global Pharmaceutical Continuous Manufacturing Market by Region, 2019-2030, $ mn	70
Table 10. Total Health Expenditure per capita in PPP International U.S. Dollars by Country	72
Table 11.  Leading National Pharmaceutical Continuous Manufacturing Market, 2019 and 2030, $ mn	74
Table 12. North America Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	77
Table 13. U.S. Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	81
Table 14. U.S. Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	81
Table 15. U.S. Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	81
Table 16. Canada Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	84
Table 17. Canada Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	84
Table 18. Canada Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	84
Table 19. Mexico Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	86
Table 20. Mexico Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	86
Table 21. Mexico Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	86
Table 22. Europe Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	90
Table 23. Germany Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	93
Table 24. Germany Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	93
Table 25. Germany Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	93
Table 26. UK Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	95
Table 27. UK Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	95
Table 28. UK Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	95
Table 29. France Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	97
Table 30. France Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	97
Table 31. France Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	97
Table 32. Spain Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	99
Table 33. Spain Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	99
Table 34. Spain Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	99
Table 35. Italy Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	101
Table 36. Italy Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	101
Table 37. Italy Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	101
Table 38. Russia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	103
Table 39. Russia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	103
Table 40. Russia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	103
Table 41. Pharmaceutical Continuous Manufacturing Market in Rest of Europe by Country, 2019-2030, $ mn	105
Table 42. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	108
Table 43. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	112
Table 44. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	112
Table 45. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	112
Table 46. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	115
Table 47. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	115
Table 48. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	115
Table 49. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	117
Table 50. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	117
Table 51. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	117
Table 52. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	119
Table 53. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	119
Table 54. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	119
Table 55. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	121
Table 56. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	121
Table 57. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	121
Table 58. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn	123
Table 59. South America Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	126
Table 60. Argentina Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	128
Table 61. Argentina Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	128
Table 62. Argentina Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	128
Table 63. Brazil Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	130
Table 64. Brazil Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	130
Table 65. Brazil Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	130
Table 66. Chile Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	132
Table 67. Chile Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	132
Table 68. Chile Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	132
Table 69. MEA Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	136
Table 70. UAE Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	138
Table 71. UAE Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	138
Table 72. UAE Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	138
Table 73. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	140
Table 74. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	140
Table 75. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	140
Table 76. South Africa Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	142
Table 77. South Africa Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	142
Table 78. South Africa Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	142
Table 79. ACG Group: Company Snapshot	148
Table 80. ACG Group: Business Segmentation	148
Table 81. ACG Group: Product Portfolio	149
Table 82. ACG Group: Revenue, 2016-2018, $ mn	149
Table 83. ACG Group: Recent Developments	149
Table 84.  Risk Evaluation for Investing in Global Market, 2019-2030	168
Table 85. Critical Success Factors and Key Takeaways	171
List Of Figures

Figure 1. Research Method Flow Chart	13
Figure 2. Breakdown of Primary Research	15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	19
Figure 5. Global Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	21
Figure 6. Impact of COVID-19 on Business	25
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Continuous Manufacturing Market	27
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical Continuous Manufacturing Market	30
Figure 9. Investment Opportunity Analysis	34
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical Continuous Manufacturing Market	37
Figure 11. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue	43
Figure 12. Global Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)	44
Figure 13. Global Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn	45
Figure 14. Global Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn	46
Figure 15. Global Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn	48
Figure 16. Global Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn	49
Figure 17. Global Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn	50
Figure 18. Global Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn	51
Figure 19. Global Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn	52
Figure 20. Global Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn	53
Figure 21. Global Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn	54
Figure 22. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue	56
Figure 23. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)	56
Figure 24. Global Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn	57
Figure 25. Global Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn	59
Figure 26. Global Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn	60
Figure 27. Global Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn	61
Figure 28. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue	64
Figure 29. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)	64
Figure 30. Global Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn	65
Figure 31. Global Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn	66
Figure 32. Global Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn	67
Figure 33. Global Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn	68
Figure 34.  Global Market Snapshot by Region	69
Figure 35.  Geographic Spread of Worldwide Pharmaceutical Continuous Manufacturing Market, 2019-2030, % of Sales Revenue	70
Figure 36. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)	71
Figure 37. Health Spending as a Share of GDP by Country, 2015 and 2030	73
Figure 38.  North American Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	76
Figure 39. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	77
Figure 40. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	78
Figure 41. U.S. Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	80
Figure 42. Canada Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	83
Figure 43.  Pharmaceutical Continuous Manufacturing Market in Mexico, 2015-2030, $ mn	85
Figure 44.  European Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	88
Figure 45. Breakdown of European Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	89
Figure 46. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	90
Figure 47.  Pharmaceutical Continuous Manufacturing Market in Germany, 2019-2030, $ mn	92
Figure 48.  Pharmaceutical Continuous Manufacturing Market in UK, 2019-2030, $ mn	94
Figure 49.  Pharmaceutical Continuous Manufacturing Market in France, 2019-2030, $ mn	96
Figure 50.  Pharmaceutical Continuous Manufacturing Market in Spain, 2019-2030, $ mn	98
Figure 51.  Pharmaceutical Continuous Manufacturing Market in Italy, 2019-2030, $ mn	100
Figure 52.  Pharmaceutical Continuous Manufacturing Market in Russia, 2019-2030, $ mn	102
Figure 53.  Pharmaceutical Continuous Manufacturing Market in Rest of Europe, 2019-2030, $ mn	104
Figure 54. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	107
Figure 55. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	107
Figure 56. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	109
Figure 57.  Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn	111
Figure 58.  Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn	114
Figure 59.  Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn	116
Figure 60.  Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn	118
Figure 61.  Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn	120
Figure 62.  Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn	122
Figure 63. South America Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	125
Figure 64. Breakdown of South America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	125
Figure 65. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	126
Figure 66.  Pharmaceutical Continuous Manufacturing Market in Argentina, 2019-2030, $ mn	127
Figure 67.  Pharmaceutical Continuous Manufacturing Market in Brazil, 2019-2030, $ mn	129
Figure 68.  Pharmaceutical Continuous Manufacturing Market in Chile, 2019-2030, $ mn	131
Figure 69.  Pharmaceutical Continuous Manufacturing Market in Rest of South America, 2019-2030, $ mn	133
Figure 70. Pharmaceutical Continuous Manufacturing Market in MEA, 2019-2030, $ mn	135
Figure 71. Breakdown of MEA Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	135
Figure 72. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	136
Figure 73.  Pharmaceutical Continuous Manufacturing Market in UAE, 2019-2030, $ mn	137
Figure 74.  Pharmaceutical Continuous Manufacturing Market in Saudi Arabia, 2019-2030, $ mn	139
Figure 75.  Pharmaceutical Continuous Manufacturing Market in South Africa, 2019-2030, $ mn	141
Figure 76. Growth Stage of Global Pharmaceutical Continuous Manufacturing Industry over the Forecast Period	144
Key Players (this may not be a complete list and extra companies can be added upon request): 
ACG Group	
Alexanderwerk	
Baker Perkins Ltd.	
Coperion GmbH	
Fette Compacting	
Freund-vector Corporation	
GEA Group AG	
Gebrüder Lödige Maschinenbau GmbH	
Gericke AG	
Glatt GmbH	
Hosokawa Micron Corporation	
Korsch AG	
Leistritz AG	
Munson Machinery Company, Inc.	
Powrex Corp	
Scott Equipment Company	
Sturtevant, Inc.	
Thermo Fisher Scientific Inc.